AKT1 and breast carcinoma: RUNX2 is a transcription factor involved in the differentiation of human osteoblasts; it is activated by multiple signaling pathways, including PI3K/AKT and NF-κB, and plays a role in bone metastasis of different cancer types, including breast cancer [158].